MarketPulse

OX2R agonist

2 articles
BenzingaBenzinga··Not Specified

Eli Lilly's Centessa Acquisition Validates Nxera's Drug Discovery Platform

Eli Lilly acquires Centessa Pharmaceuticals, which developed sleep-disorder treatments with Nxera Pharma. Nxera retains royalties, milestones, and equity stake.
LLYCNTAacquisitiondrug discovery
GlobeNewswire Inc.GlobeNewswire Inc.··Nxera Pharma

Eli Lilly Acquires Centessa Pharmaceuticals in Sleep-Wake Drug Push

Eli Lilly acquires Centessa Pharmaceuticals, developer of OX2R agonists for sleep disorders co-created with Nxera Pharma, which retains milestone payments and royalties.
LLYCNTAacquisitiondrug discovery